Ipatia Emframidou
Direttore/Membro del Consiglio presso Colonis Pharma Ltd.
Posizioni attive di Ipatia Emframidou
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Colonis Pharma Ltd.
 Colonis Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Triley Bidco Ltd., Colonis Pharma Ltd. is a British pharmaceutical company that manufactures and supplies pharmaceutical products. The company is based in Weybridge, UK. The company was founded in 2005 by Thomas Engelen. Colonis Pharma was acquired by Quantum Pharma Holdings Ltd., part of Triley Bidco Ltd. from November 02, 2017 on September 30, 2012. | Direttore/Membro del Consiglio | 11/08/2017 | - |
Storia della carriera di Ipatia Emframidou
Statistiche
Distribuzione geografica
| Regno Unito | 2 |
Posizioni
| Director/Board Member | 1 |
Settori
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Colonis Pharma Ltd.
Colonis Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Triley Bidco Ltd., Colonis Pharma Ltd. is a British pharmaceutical company that manufactures and supplies pharmaceutical products. The company is based in Weybridge, UK. The company was founded in 2005 by Thomas Engelen. Colonis Pharma was acquired by Quantum Pharma Holdings Ltd., part of Triley Bidco Ltd. from November 02, 2017 on September 30, 2012. | Health Technology |
- Borsa valori
- Insiders
- Ipatia Emframidou
- Esperienza
